BIP_BASE

Ischemia Care Biomarkers of Acute Stroke Etiology (BASE)

The proposed study will validate the clinical use of new biomarker blood tests to identify blood components that may differentiate between diverse stroke etiologies and clinical outcomes.

Key Eligibilities:
-Ischemic stroke.
-Arrival to the ED or hospital within 8 hours of symptom onset or last known normal time.
-Head CT or MRI ruling out other pathology.

**Other protocol-defined inclusion/exclusion criteria may apply. Please click on the NCT Number (below) to learn more about the study at clinicaltrials.gov.**
N/A
NCT02014896
Neurosciences, All Other
Stroke
Ted Lowenkopf, M.D.
Ischemia Care, LLC
Robin Kintner
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center